参考文献/References:
[1] 李尊岭.转录因子E2F1调控小细胞肺癌浸润转移机制的研究[D].济南:山东大学,2014.
[2] 赵 铎,高宝安.中晚期非小细胞肺癌联合治疗研究进展[J].海南医学,2016,27(3):438-441.
[3] 唐东军,张丽华.化疗对非小细胞肺癌患者生存质量的影响[J].癌症进展,2009,7(4):472-475.
[4] 单 磊,张卫东,张 川,等.皂苷类成分抗肿瘤活性的研究进展[J].中草药,2005,36(2):295-298.
[5] 陈 颖,周 岩,曹银萍.中药皂苷类化合物体外抗肿瘤研究进展[J].中国医院药学杂志,2011,31(7):591-593.
[6] 欧阳丽娜,向大位,吴 雪,等.竹节参化学成分及药理活性研究进展[J].中草药,2010,41(6):1023-1027.
[7] 左 锐,袁 丁.竹节参化学成分和药理活性研究进展[J].时珍国医国药,2005,16(9):838-839.
[8] Duan J,Yin Y,Wei G,et al.Chikusetsu saponin Ⅳa confers cardioprotection via SIRT1/ERK1/2 and Homer1a pathway[J].Scientific Reports,2015,5:18123.
[9] 周志勇,陈亚昕,李德鸿,等.竹节参总皂苷通过抑制NF-κB介导的炎性反应改善小鼠肿瘤恶病质研究[J].中国药理学通报,2018,34(4):532-537.
[10] 惠小娜,胡 培,张晨宁,等.肠道菌群对人参皂苷防治肺癌活性影响的研究进展[J].中药药理与临床,2017,33(1):218-223.
[11] Motoyoshi Y,Kaminoda K,Saitoh O,et al.Different mechanisms for anti-tumor effects of low- and high-dose cyclophosphamide[J].Oncology Reports,2006,16(1):141-146.
[12] Krüger K,Mooren FC.T cell homing and exercise[J].Exercise Immunology Review,2007,13(13):37-54.
[13] Marchesi F,Piemonti L,Mantovani A,et al.Molecular mechanisms of perineural invasion,a forgotten pathway of dissemination and metastasis[J].Cytokine Growth Factor Rev,2010,21(1):77-82.
[14] Watabe K.The role of tumor-associated macrophage in tumor progression[J].Frontiers in Bioscience,2012,4:787-798.
[15] Joyce JA,Pollard JW.Microenvironmental regulation of metastasis[J].Nature Reviews Cancer,2008,9(4):239-252.
[16] Kim S,Takahashi H,Lin WW,et al.Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis[J].Nature,2009,457(7225):102-106.
[17] Jakowlew SB.Transforming growth factor-beta in cancer and metastasis[J].Cancer Metastasis Rev,2006,25(3):435-457.
[18] Wu Y,Zhou BP.TNF-alpha/NF-kappaB/Snail pathway in cancer cell migration and invasion[J].Br J Cancer,2010,102(4):639-644.
[19] 王羽超,周红光,陈海彬,等.Toll样受体/核因子-κB信号通路与恶性肿瘤的研究进展[J].辽宁中医杂志,2011,38(4):785-787.